Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis

BACKGROUND: The impact of sacubitril–valsartan on heart failure (HF) patients with preserved ejection fractions (HFpEF) is uncertain. The purpose of this meta-analysis was to explore the clinical advantages and safety of sacubitril–valsartan in patients with HFpEF. METHODS: PubMed and Web of Science...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Christian, Paolillo, Stefania, Gargiulo, Paola, Marzano, Federica, Asile, Gaetano, Parlati, Antonio Luca Maria, Chirico, Alfonsina, Nardi, Ermanno, Buonocore, Davide, Colella, Angela, Perrone-Filardi, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research articles: Heart Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794138/
https://www.ncbi.nlm.nih.gov/pubmed/36574300
http://dx.doi.org/10.2459/JCM.0000000000001411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794138/
https://www.ncbi.nlm.nih.gov/pubmed/36574300
http://dx.doi.org/10.2459/JCM.0000000000001411

Ejemplares similares